1.87
price up icon2.75%   0.05
after-market Handel nachbörslich: 1.88 0.010 +0.53%
loading
Schlusskurs vom Vortag:
$1.82
Offen:
$1.845
24-Stunden-Volumen:
105.39K
Relative Volume:
0.30
Marktkapitalisierung:
$58.34M
Einnahmen:
$1.05M
Nettoeinkommen (Verlust:
$-48.82M
KGV:
-1.0219
EPS:
-1.83
Netto-Cashflow:
$-47.49M
1W Leistung:
+17.61%
1M Leistung:
+23.03%
6M Leistung:
+39.55%
1J Leistung:
-76.62%
1-Tages-Spanne:
Value
$1.8335
$1.89
1-Wochen-Bereich:
Value
$1.57
$1.89
52-Wochen-Spanne:
Value
$1.06
$8.285

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
Firmenname
Actinium Pharmaceuticals Inc
Name
Telefon
646-767-3870
Name
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Name
Mitarbeiter
25
Name
Twitter
@actiniumpharma
Name
Nächster Verdiensttermin
2025-03-14
Name
Neueste SEC-Einreichungen
Name
ATNM's Discussions on Twitter

Vergleichen Sie ATNM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.87 56.78M 1.05M -48.82M -47.49M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-07 Herabstufung B. Riley Securities Buy → Neutral
2024-05-14 Eingeleitet Stephens Overweight
2023-09-06 Eingeleitet HSBC Securities Buy
2023-02-21 Herabstufung William Blair Outperform → Mkt Perform
2022-09-08 Eingeleitet Cantor Fitzgerald Overweight
2022-08-25 Eingeleitet B. Riley Securities Buy
2020-11-05 Eingeleitet Alliance Global Partners Buy
2017-12-06 Eingeleitet B. Riley FBR, Inc. Buy
2017-10-23 Fortgesetzt ROTH Capital Buy
2017-09-14 Eingeleitet Maxim Group Buy
2016-08-25 Eingeleitet ROTH Capital Buy
2016-02-29 Eingeleitet H.C. Wainwright Buy
2015-10-15 Eingeleitet FBR Capital Outperform
2014-10-01 Eingeleitet MLV & Co Buy
2014-07-22 Eingeleitet Canaccord Genuity Buy
Alle ansehen

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

pulisher
Jul 23, 2025

Is Actinium Pharmaceuticals Inc. a good long term investmentFree Stock Market Beginners Guide - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Actinium Pharmaceuticals Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Actinium Pharmaceuticals Inc. stock priceExponential wealth increase - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Actinium Pharmaceuticals Inc. stockMarket-crushing stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Lead Plaintiff Appointed in Actinium Pharmaceuticals Class Action - TradingView

Jul 21, 2025
pulisher
Jul 17, 2025

Is Actinium Pharmaceuticals Inc. stock a growth or value playFree Access to Investment Community - beatles.ru

Jul 17, 2025
pulisher
Jul 15, 2025

How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser

Jul 15, 2025
pulisher
Jul 02, 2025

Actinium Highlights ATNM 400 Progress at SNMMI Conference - Yahoo.co

Jul 02, 2025
pulisher
Jun 30, 2025

Actinium’s ATNM-400 demonstrates superior efficacy in prostate cancer - BioWorld MedTech

Jun 30, 2025
pulisher
Jun 23, 2025

Innovative Prostate Cancer Treatment ATNM-400 Shows Promising Pr - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire

Jun 23, 2025
pulisher
Jun 19, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

Jun 19, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $148,000 Stake in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire

Jun 10, 2025
pulisher
Jun 10, 2025

Life Sciences Investor Forum Agenda Announced for June 11th-12th - GlobeNewswire

Jun 10, 2025
pulisher
Jun 08, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Increases Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for InvestorsContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Actinium Pharmaceuticals, Inc. to Contact the Firm Today! - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 03, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Jun 02, 2025
pulisher
May 28, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire

May 28, 2025
pulisher
May 27, 2025

Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire

May 27, 2025
pulisher
May 27, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire

May 27, 2025
pulisher
May 26, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

May 26, 2025
pulisher
May 26, 2025

FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire

May 26, 2025
pulisher
May 26, 2025

2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse

May 26, 2025
pulisher
May 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Hav - GuruFocus

May 26, 2025
pulisher
May 26, 2025

ATNM Deadline: ATNM Investors with Losses in Excess of $100K Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar

May 26, 2025
pulisher
May 26, 2025

Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - Stockhouse

May 26, 2025
pulisher
May 26, 2025

Press releases provided by CNW - Techaeris

May 26, 2025
pulisher
May 25, 2025

Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Contact Levi & Korsinsky to Join Class Action Before May 27, 2025 - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, ... - Eagle-Tribune

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire

May 25, 2025
pulisher
May 25, 2025

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM - GlobeNewswire Inc.

May 25, 2025
pulisher
May 25, 2025

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) Shareholders of Class Action Lawsuit and May 27, 2025 Deadline - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider

May 25, 2025
pulisher
May 24, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - StreetInsider

May 24, 2025

Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):